News
International experts in colorectal cancer meet in Bellvitge within the European project SYSCOL
On Monday, November 4th in the Auditorium of the University Hospital of Bellvitge be held an open day to all researchers
IT-LIVER Project partners will meet again in Vienna
On the 25th and 26th September 2013 IDIBELL hosted the first workshop of the European project IT-Liver, included in the Marie Curie ITN (Initial Training Network) Programme. The next training sessions will be held on 27th and 28th February at the University of Vienna. The IT-LIVER project’s mission is to provide a multidisciplinary research training […]
Brain mapping and neurophysiological monitoring allows a greater degree of tumor resection
The University Hospital of Bellvitge is a pioneer in Spain in the intraoperative use of these techniques in patients with brain tumors Neurophysiological monitoring has reduced to less than 5 % incidence of permanent deficits mobility of patients operated
Bart Vanhaesebroeck, bridging gaps between basic and translational research
The professor of the Barts Cancer Institute of London, Bart Vanhaesebroeck, offered last October 11, in the frame of the IDIBELL Seminars, a summary of his research on the signaling of the PI3 Kinase. Dr. Vanhaesebroeck stressed that he has spent 20 years researching in the field of PI3K, where he began by cloning one […]
Alterations in DICER protein promote metastasis in colon cancer
MicroRNAs Stem cells control the growth and development of tumor metastasis Article’s reference Impaired DICER1 function promotes stemness and metastasis in colon cancer
Manel Esteller, corresponding academic of the Royal Academy of Medicine of Valencia
The researcher Manel Esteller, director of the Epigenetics and Cancer Biology IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor was elected Corresponding Academic of the Royal Academy of Medicine of Valencia (RAMCV). The appointment wants to recognize the scientific career of Manel Esteller in the field of epigenetics and its […]
IDIBELL’s researchers discover a potential therapeutic target to slow the growth of tumors
A study by the Bellvitge Institute of Biomedical Research (IDIBELL ) led by the head of the research group in signaling pathways in angiogenesis , Mariona Graupera concludes that p110alpha protein inhibition in mice causes a reduction of tumor growth associated with a defect in blood vessel formation . Study results were published in the […]
Researchers discover the genetic signature of highly aggressive small lung tumours
Lung cancer is currently the most lethal in the world. The main cause of these tumors is the tobacco and it is usually diagnosed in advanced stages when there are already few treatment options. There is a subgroup of tumors of the lung that thanks to diagnostic advances can be detected in early stages and […]